Wolffenbuttel BH - Search Results

1

Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides.

de Vries R, Perton FG, Dallinga-Thie GM, van Roon AM, Wolffenbuttel BH, van Tol A, Dullaart RP. de Vries R, et al. Among authors: wolffenbuttel bh. Diabetes. 2005 Dec;54(12):3554-9. doi: 10.2337/diabetes.54.12.3554. Diabetes. 2005. PMID: 16306375

2

Clinical characteristics and management of diabetic patients residing in a nursing home.

Wolffenbuttel BH, van Vliet S, Knols AJ, Slits WL, Sels JP, Nieuwenhuijzen Kruseman AC. Wolffenbuttel BH, et al. Diabetes Res Clin Pract. 1991 Sep;13(3):199-206. doi: 10.1016/0168-8227(91)90064-k. Diabetes Res Clin Pract. 1991. PMID: 1959483

3

Tissue factor pathway inhibitor activity in patients with IDDM.

Leurs PB, van Oerle R, Hamulyak K, Wolffenbuttel BH. Leurs PB, et al. Among authors: wolffenbuttel bh. Diabetes. 1995 Jan;44(1):80-4. doi: 10.2337/diab.44.1.80. Diabetes. 1995. PMID: 7813818 Clinical Trial.

4

Arteriolar reactivity in conscious diabetic rats: influence of aminoguanidine treatment.

Crijns FR, Struijker Boudier HA, Wolffenbuttel BH. Crijns FR, et al. Among authors: wolffenbuttel bh. Diabetes. 1998 Jun;47(6):918-23. doi: 10.2337/diabetes.47.6.918. Diabetes. 1998. PMID: 9604869

5

Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions.

Huvers FC, De Leeuw PW, Houben AJ, De Haan CH, Hamulyak K, Schouten H, Wolffenbuttel BH, Schaper NC. Huvers FC, et al. Among authors: wolffenbuttel bh. Diabetes. 1999 Jun;48(6):1300-7. doi: 10.2337/diabetes.48.6.1300. Diabetes. 1999. PMID: 10342820

6

Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes.

Leurs PB, Stolk RP, Hamulyak K, Van Oerle R, Grobbee DE, Wolffenbuttel BH. Leurs PB, et al. Among authors: wolffenbuttel bh. Diabetes Care. 2002 Aug;25(8):1340-5. doi: 10.2337/diacare.25.8.1340. Diabetes Care. 2002. PMID: 12145232

7

Physician, organizational, and patient factors associated with suboptimal blood pressure management in type 2 diabetic patients in primary care.

Schaars CF, Denig P, Kasje WN, Stewart RE, Wolffenbuttel BH, Haaijer-Ruskamp FM. Schaars CF, et al. Among authors: wolffenbuttel bh. Diabetes Care. 2004 Jan;27(1):123-8. doi: 10.2337/diacare.27.1.123. Diabetes Care. 2004. PMID: 14693977

8

The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.

Borggreve SE, Hillege HL, Wolffenbuttel BH, de Jong PE, Bakker SJ, van der Steege G, van Tol A, Dullaart RP; PREVEND Study Group. Borggreve SE, et al. Among authors: wolffenbuttel bh. J Clin Endocrinol Metab. 2005 Jul;90(7):4198-204. doi: 10.1210/jc.2005-0182. Epub 2005 Apr 19. J Clin Endocrinol Metab. 2005. PMID: 15840744

9

[Tissue-specific changes in cortisol metabolism and their potential role in the metabolic syndrome].

Kerstens MN, Wolffenbuttel BH, Dullaart RP. Kerstens MN, et al. Among authors: wolffenbuttel bh. Ned Tijdschr Geneeskd. 2005 Apr 16;149(16):871-6. Ned Tijdschr Geneeskd. 2005. PMID: 15868991 Review. Dutch.

10

Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects.

De Vries R, Wolffenbuttel BH, Sluiter WJ, van Tol A, Dullaart RP. De Vries R, et al. Among authors: wolffenbuttel bh. Clin Lab. 2005;51(7-8):403-9. Clin Lab. 2005. PMID: 16122151

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

438 results

Search Page

Filters